{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:18:49Z","timestamp":1756462729209,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12328-020-01164-x","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T19:03:35Z","timestamp":1593284615000},"page":"935-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor lysis syndrome in a patient with metastatic melanoma treated with nivolumab"],"prefix":"10.1007","volume":"13","author":[{"given":"Saiho","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-0101","authenticated-orcid":false,"given":"Takeshi","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriho","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Shimakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"1164_CR1","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364:1844\u201354.","journal-title":"N Engl J Med"},{"key":"1164_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373:23\u201334.","journal-title":"N Engl J Med"},{"key":"1164_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30\u20139.","journal-title":"N Engl J Med"},{"key":"1164_CR4","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1111\/jdv.13733","volume":"31","author":"M Masson Regnault","year":"2017","unstructured":"Masson Regnault M, Ofaiche J, Boulinguez S, et al. Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab. J Eur Acad Dermatol Venereol. 2017;31:e73\u2013e7474.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1164_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12032-016-0854-5","volume":"33","author":"MW Meeks","year":"2016","unstructured":"Meeks MW, Hammami MB, Robbins KJ, et al. Tumor lysis syndrome and metastatic melanoma. Med Oncol. 2016;33:134.","journal-title":"Med Oncol"},{"key":"1164_CR6","first-page":"456","volume":"16","author":"L Dar","year":"2014","unstructured":"Dar L, Gendelman O, Amital H. Tumor lysis syndrome presenting in a patient with metastatic melanoma treated with radiation therapy. Isr Med Assoc J. 2014;16:456\u20137.","journal-title":"Isr Med Assoc J"},{"key":"1164_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12032-012-0364-z","volume":"30","author":"M Mouallem","year":"2013","unstructured":"Mouallem M, Zemer-Wassercug N, Kugler E, et al. Tumor lysis syndrome and malignant melanoma. Med Oncol. 2013;30:364.","journal-title":"Med Oncol"},{"key":"1164_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-4632.2009.04087.x","volume":"48","author":"Y Nakamura","year":"2009","unstructured":"Nakamura Y, Nakamura Y, Hori E, et al. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Int J Dermatol. 2009;48:763\u20137.","journal-title":"Int J Dermatol"},{"key":"1164_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1468-3083.2008.03058.x","volume":"23","author":"E Borne","year":"2009","unstructured":"Borne E, Serafi R, Piette F, et al. Tumour lysis syndrome induced by corticosteroid in metastatic melanoma presenting with initial hyperkalemia. J Eur Acad Dermatol Venereol. 2009;23:855\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1164_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.0303-6987.2003.00154.x","volume":"31","author":"KJ Busam","year":"2004","unstructured":"Busam KJ, Wolchok J, Jungbluth AA, et al. Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma. J Cutan Pathol. 2004;31:274\u201380.","journal-title":"J Cutan Pathol"},{"key":"1164_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00000441-200203000-00007","volume":"323","author":"GS Habib","year":"2002","unstructured":"Habib GS, Saliba WR. Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature. Am J Med Sci. 2002;323:155\u20137.","journal-title":"Am J Med Sci"},{"key":"1164_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ndt\/16.1.188","volume":"16","author":"J Stoves","year":"2001","unstructured":"Stoves J, Richardson D, Patel H. Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy. Nephrol Dial Transplant. 2001;16:188\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1164_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.0.CO;2-3","volume":"85","author":"MP Castro","year":"1999","unstructured":"Castro MP, VanAuken J, Spencer-Cisek P, et al. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Cancer. 1999;85:1055\u20139.","journal-title":"Cancer"},{"key":"1164_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood.V83.1.56.56","volume":"83","author":"LM Minasian","year":"1994","unstructured":"Minasian LM, Szatrowski TP, Rosenblum M, et al. Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma. Blood. 1994;83:56\u201364.","journal-title":"Blood"},{"key":"1164_CR15","first-page":"5","volume":"1","author":"D Brunnhoelzl","year":"2017","unstructured":"Brunnhoelzl D, Wang J. Acute tumor lysis syndrome after anti-pd-1 immunotherapy nivolumab for metastatic melanoma. J Mol Oncol Res. 2017;1:5\u20136.","journal-title":"J Mol Oncol Res"},{"key":"1164_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-319-22539-5_9","volume":"167","author":"MK Callahan","year":"2016","unstructured":"Callahan MK, Flaherty CR, Postow MA. Checkpoint blockade for the treatment of advanced melanoma. Cancer Treat Res. 2016;167:231\u201350.","journal-title":"Cancer Treat Res"},{"key":"1164_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.clon.2006.09.005","volume":"18","author":"C Gemici","year":"2006","unstructured":"Gemici C. Tumour lysis syndrome in solid tumours. Clin Oncol. 2006;18:773\u201380.","journal-title":"Clin Oncol"},{"key":"1164_CR18","first-page":"1005","volume":"1","author":"EO Cordrey","year":"2018","unstructured":"Cordrey EO, Wang J. Tumor lysis syndrome associated with immune checkpoint blockade in solide tumors. Jpn J Cancer Oncol Res. 2018;1:1005.","journal-title":"Jpn J Cancer Oncol Res"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-020-01164-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T23:34:00Z","timestamp":1624750440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-020-01164-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01164-x","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2020,6,27]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Shuichi Kaneko received lecture fees from Bristol-Myers Squibb, and research funding from ONO Pharmaceutical Co., LTD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"We obtained consent for publication in print and electronically from the patient\u2019s family.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}